Intensity Therapeutics, Inc. Common stock
INTS
$3.38-1.17%
End of day · as of Oct 16, 2026, 6:16 AM ET
Mkt cap
$7.69M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-2.08
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Use this INTS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full INTS income, balance, and cash tables.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company in the Healthcare sector.
Latest cached Intensity Therapeutics, Inc. Common stock (INTS) net income for FY2025 was -$11.6M. Statements: https://lician.com/financials/ints
Intensity Therapeutics, Inc. Common stock (INTS) market capitalization is $7.7M on the latest cached snapshot.
Intensity Therapeutics, Inc. Common stock (INTS) cached previous close $3.42; day range $3.35 – $3.42; volume 8,321. Session quote: https://lician.com/quote/ints
Intensity Therapeutics, Inc. Common stock (INTS) latest cached earnings event is "INTS earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached INTS filing is 8-K · Aug 11, 2026. Filings: https://lician.com/sec/ints